Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 153–160 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Advaxis Inc. AL101 - (TENACITY) Triple negative breast cancer Phase 2 Intravenous Oncology
Advaxis Inc. Aspacytarabine (BST-236) Acute myeloid leukemia (AML) Phase 2 Intravenous Oncology
Adverum Biotechnologies Inc. Lxo-vec (ixoberogene soroparvovec, ADVM-022) - (OPTIC) Wet age-related macular degeneration (Wet-AMD) Phase 2 Data Released Intravitreal injection Opthalmic
Adverum Biotechnologies Inc. Ixo-vec (ixoberogene soroparvovec, ADVM-022) - (ARTEMIS) Wet age-related macular degeneration (AMD) Phase 3 Ongoing Intravitreal injection Opthalmic
Adverum Biotechnologies Inc. Ixoberogene soroparvovec (Ixo-vec) - (INFINITY) Diabetic macular edema (DME) Phase 2 Trial Discontinued Intravitreal injection Opthalmic
Adverum Biotechnologies Inc. Lxo-vec (ixoberogene soroparvovec, ADVM-022) - (OPTIC) Wet age-related macular degeneration (Wet-AMD) Phase 2 Data Released Intravitreal injection Opthalmic
Adverum Biotechnologies Inc. Ixo-vec (ixoberogene soroparvovec, ADVM-022) - (AQUARIUS) wet AMD Phase 3 Trial Planned Intravitreal injection Opthalmic
Adverum Biotechnologies Inc. Ixoberogene soroparvovec (Ixo-vec) - (INFINITY) Diabetic macular edema (DME) Phase 2 Trial Discontinued Intravitreal injection Opthalmic